DUTASTERIDE

DUTASTERIDE was reported 8271 times

DUTASTERIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MINIMUM INHIBITORY CONCENTRATION 24 0.7273
1 5-ALPHA-REDUCTASE DEFICIENCY 7 0.6364
2 SPIROMETRY ABNORMAL 294 0.4916
3 MITE ALLERGY 297 0.4534
4 MYCOTIC ALLERGY 297 0.3474
5 DUST ALLERGY 300 0.3058
6 PULMONARY VASCULITIS 158 0.2937
7 TOTAL LUNG CAPACITY ABNORMAL 107 0.2751
8 CAPILLARITIS 64 0.2319
9 OCCUPATIONAL EXPOSURE TO AIR CONTAMINANTS 10 0.2273
10 AMAUROSIS FUGAX 226 0.2098
11 CONJUNCTIVITIS ALLERGIC 309 0.2085
12 DIHYDROTESTOSTERONE INCREASED 5 0.1724
13 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 111 0.1514
14 NEURITIS 161 0.1042
15 NORMOCHROMIC NORMOCYTIC ANAEMIA 298 0.0991
16 SUBARACHNOID HAEMATOMA 13 0.0977
17 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 30 0.0971
18 GENITALIA EXTERNAL AMBIGUOUS 14 0.0809
19 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 153 0.0750
20 BROWN-SEQUARD SYNDROME 5 0.0735
21 5-HYDROXYINDOLACETIC ACID IN URINE INCREASED 4 0.0727
22 PENILE NECROSIS 8 0.0721
23 RESPIRATORY SYMPTOM 169 0.0594
24 DRUG DISPENSED TO WRONG PATIENT 48 0.0503
25 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 7 0.0493
26 CONTRAINDICATED PRODUCT PRESCRIBED 77 0.0458
27 FORCED EXPIRATORY VOLUME DECREASED 126 0.0444
28 URINARY TRACT DISORDER 198 0.0439
29 BLOOD ELECTROLYTES INCREASED 5 0.0427
30 POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME 11 0.0387
31 INFERIOR VENA CAVA DILATATION 8 0.0379
32 ARTERIOSCLEROSIS CORONARY ARTERY 247 0.0372
33 PROSTATE EXAMINATION ABNORMAL 9 0.0372
34 HAEMORRHAGIC STROKE 247 0.0316
35 MYCOBACTERIUM KANSASII INFECTION 5 0.0305
36 PULMONARY ALVEOLAR HAEMORRHAGE 163 0.0290
37 ARTERIOSCLEROSIS 273 0.0290
38 VENTRICULAR ASYSTOLE 5 0.0287
39 NEUROLOGICAL SYMPTOM 162 0.0283
40 FLOPPY IRIS SYNDROME 10 0.0271
41 FULL BLOOD COUNT ABNORMAL 282 0.0266
42 FORCED VITAL CAPACITY DECREASED 17 0.0260
43 SALMONELLA BACTERAEMIA 5 0.0242
44 EYE HAEMATOMA 6 0.0228
45 NODULE 297 0.0227
46 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 363 0.0214
47 WRONG STRENGTH 7 0.0212
48 FLUID REPLACEMENT 7 0.0207
49 TACHYARRHYTHMIA 51 0.0204
50 OCULAR DISCOMFORT 226 0.0201
51 BLADDER TAMPONADE 6 0.0198
52 HYPONATRAEMIC SYNDROME 6 0.0186
53 OBSTRUCTIVE AIRWAYS DISORDER 206 0.0185
54 MEDICAL DEVICE SITE HAEMORRHAGE 5 0.0176
55 GENERALISED OEDEMA 217 0.0175
56 PULMONARY FUNCTION TEST ABNORMAL 27 0.0173
57 MYOCLONIC EPILEPSY 25 0.0165
58 MITRAL VALVE REPAIR 5 0.0155
59 DIFFUSE LARGE B-CELL LYMPHOMA STAGE IV 5 0.0152
60 SPERM CONCENTRATION DECREASED 5 0.0145
61 WRONG PATIENT RECEIVED PRODUCT 42 0.0143
62 LOWER URINARY TRACT SYMPTOMS 5 0.0138
63 CLOSTRIDIUM TEST POSITIVE 30 0.0136
64 PHIMOSIS 10 0.0136
65 HEAD DISCOMFORT 234 0.0132
66 LUNG HYPERINFLATION 11 0.0128
67 VASCULITIS 143 0.0123
68 ALTERED STATE OF CONSCIOUSNESS 254 0.0117
69 BRONCHIAL HYPERREACTIVITY 14 0.0116
70 RETROGRADE EJACULATION 9 0.0113
71 BLOOD GASES ABNORMAL 6 0.0111
72 THERAPEUTIC RESPONSE DELAYED 30 0.0107
73 PENILE SIZE REDUCED 10 0.0105
74 TRANSURETHRAL PROSTATECTOMY 5 0.0100
75 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 8 0.0097
76 PHOTOPHOBIA 178 0.0095
77 HYPOXIA 330 0.0094
78 HAEMATEMESIS 235 0.0093
79 PRESYNCOPE 222 0.0091
80 INTENTION TREMOR 5 0.0088
81 PULMONARY FIBROSIS 168 0.0087
82 DISORGANISED SPEECH 15 0.0081
83 DIPLOPIA 211 0.0081
84 INTESTINAL PSEUDO-OBSTRUCTION 7 0.0080
85 PROSTATOMEGALY 31 0.0079
86 ASCITES 226 0.0077
87 PRODUCTIVE COUGH 364 0.0076
88 HAEMATURIA 261 0.0076
89 BLOOD PRESSURE DIASTOLIC ABNORMAL 19 0.0075
90 BODY MASS INDEX INCREASED 10 0.0074
91 KLEBSIELLA BACTERAEMIA 7 0.0074
92 HAEMORRHAGIC TRANSFORMATION STROKE 11 0.0073
93 BLOOD PRESSURE SYSTOLIC ABNORMAL 18 0.0073
94 WHEEZING 429 0.0072
95 CEREBRAL VENOUS SINUS THROMBOSIS 6 0.0071
96 PERINEAL PAIN 5 0.0070
97 SEMEN VOLUME DECREASED 7 0.0070
98 HAEMOPTYSIS 193 0.0069
99 GENITAL HYPOAESTHESIA 7 0.0069
100 SOFT TISSUE INJURY 5 0.0066
101 ABNORMAL SLEEP-RELATED EVENT 8 0.0061
102 INTERCEPTED PRODUCT PRESCRIBING ERROR 8 0.0060
103 EJACULATION DISORDER 17 0.0060
104 HYPORESPONSIVE TO STIMULI 7 0.0060
105 GROIN ABSCESS 7 0.0059
106 BLINDNESS 240 0.0059
107 WRONG PRODUCT ADMINISTERED 39 0.0058
108 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 271 0.0056
109 NEUROMYOPATHY 6 0.0056
110 TESTICULAR SWELLING 7 0.0055
111 AUTONOMIC NERVOUS SYSTEM IMBALANCE 16 0.0055
112 CARDIO-RESPIRATORY ARREST 228 0.0054
113 PROSTATE CANCER METASTATIC 18 0.0054
114 LIBIDO DISORDER 7 0.0054
115 HYPOTHYROIDISM 171 0.0053
116 ENCEPHALITIS AUTOIMMUNE 7 0.0053
117 BASOPHIL COUNT INCREASED 4 0.0053
118 INTRAVENTRICULAR HAEMORRHAGE 13 0.0052
119 MACULAR HOLE 7 0.0052
120 BENIGN PROSTATIC HYPERPLASIA 26 0.0050
121 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 354 0.0050
122 COMA 232 0.0049
123 PROCEDURAL HAEMORRHAGE 19 0.0049
124 HYPERTONIC BLADDER 14 0.0048
125 TINNITUS 219 0.0048
126 PLASMA CELL MYELOMA REFRACTORY 6 0.0045
127 TESTICULAR PAIN 14 0.0044
128 EYE PAIN 249 0.0044
129 LABYRINTHITIS 11 0.0043
130 NEPHROGENIC DIABETES INSIPIDUS 5 0.0043
131 ORTHOSTATIC HYPOTENSION 75 0.0043
132 ERECTILE DYSFUNCTION 109 0.0042
133 LUNG DISORDER 206 0.0042
134 BLADDER NEOPLASM 7 0.0041
135 THROMBOSIS 326 0.0040
136 PRODUCT PRESCRIBING ISSUE 88 0.0040
137 EJACULATION FAILURE 8 0.0040
138 FOOD INTERACTION 7 0.0040
139 CRANIOCEREBRAL INJURY 12 0.0040
140 HAEMORRHAGE URINARY TRACT 10 0.0039
141 NIPPLE PAIN 8 0.0039
142 VIOLENCE-RELATED SYMPTOM 6 0.0039
143 CEREBRAL VENOUS THROMBOSIS 7 0.0039
144 ASTHMA 435 0.0038
145 FOREIGN BODY IN THROAT 12 0.0038
146 URINARY TRACT OBSTRUCTION 9 0.0038
147 HYPERREFLEXIA 13 0.0037
148 CALCULUS BLADDER 5 0.0037
149 PULMONARY EMBOLISM 344 0.0036
150 SLEEP TALKING 6 0.0035
151 FREEZING PHENOMENON 13 0.0035
152 PEMPHIGOID 26 0.0034
153 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
154 ACUTE LUNG INJURY 4 0.0034
155 BLOOD COUNT ABNORMAL 51 0.0034
156 BLOOD SODIUM INCREASED 9 0.0033
157 OBESITY 53 0.0033
158 URINARY BLADDER HAEMORRHAGE 7 0.0033
159 CALCULUS URINARY 5 0.0032
160 SYNCOPE 322 0.0032
161 SOPOR 42 0.0032
162 PROSTATIC SPECIFIC ANTIGEN INCREASED 43 0.0031
163 RALES 18 0.0031
164 BICYTOPENIA 6 0.0031
165 MEAN CELL HAEMOGLOBIN INCREASED 5 0.0030
166 NASAL DISORDER 8 0.0030
167 TACHYCARDIA 266 0.0030
168 POTENTIATING DRUG INTERACTION 10 0.0030
169 SPUTUM DISCOLOURED 28 0.0029
170 DYSPNOEA EXERTIONAL 109 0.0029
171 HYPOSPADIAS 6 0.0029
172 URINARY RETENTION 95 0.0028
173 LEFT VENTRICULAR DYSFUNCTION 19 0.0028
174 MITRAL VALVE DISEASE 5 0.0028
175 BLOOD TESTOSTERONE INCREASED 6 0.0028
176 BRONCHIECTASIS 18 0.0027
177 DIVERTICULUM INTESTINAL HAEMORRHAGIC 6 0.0027
178 LOSS OF LIBIDO 24 0.0027
179 HAEMATOCRIT INCREASED 6 0.0026
180 BLOOD PRESSURE SYSTOLIC INCREASED 51 0.0026
181 GINGIVAL RECESSION 5 0.0026
182 BRAIN INJURY 26 0.0026
183 CONTRAINDICATED PRODUCT ADMINISTERED 78 0.0026
184 BLOOD PRESSURE DIASTOLIC DECREASED 19 0.0026
185 SEPSIS 287 0.0026
186 BILIRUBIN CONJUGATED INCREASED 6 0.0026
187 TRIGEMINAL NEURALGIA 10 0.0025
188 STARING 6 0.0025
189 HEART RATE DECREASED 86 0.0024
190 CHILLS 287 0.0024
191 SUBDURAL HAEMATOMA 35 0.0024
192 BREAST ENLARGEMENT 8 0.0024
193 PRODUCT ADMINISTRATION ERROR 49 0.0024
194 NEAR DEATH EXPERIENCE 8 0.0024
195 MUCOUS STOOLS 12 0.0024
196 CHEST INJURY 5 0.0024
197 LUMBAR SPINAL STENOSIS 7 0.0024
198 BODY TEMPERATURE DECREASED 23 0.0023
199 AUTOIMMUNE HAEMOLYTIC ANAEMIA 8 0.0023
200 UPPER GASTROINTESTINAL HAEMORRHAGE 39 0.0023
201 LANGUAGE DISORDER 5 0.0023
202 DEPRESSION SUICIDAL 8 0.0023
203 PROSTATITIS 7 0.0023
204 HYPOMAGNESAEMIA 32 0.0023
205 PNEUMONIA FUNGAL 9 0.0023
206 JAUNDICE CHOLESTATIC 8 0.0023
207 ATRIAL FLUTTER 18 0.0023
208 OLIGURIA 14 0.0023
209 CHOLESTATIC LIVER INJURY 5 0.0022
210 BLOOD LOSS ANAEMIA 5 0.0022
211 POLYMYALGIA RHEUMATICA 7 0.0022
212 HEPATOCELLULAR INJURY 31 0.0022
213 SPINAL STENOSIS 9 0.0022
214 BLOOD PRESSURE INCREASED 332 0.0022
215 LARGE INTESTINE POLYP 15 0.0022
216 FLAT AFFECT 5 0.0022
217 DYSURIA 79 0.0021
218 BREAST TENDERNESS 16 0.0021
219 CARDIAC FAILURE CHRONIC 9 0.0021
220 DRUG INTERACTION 333 0.0021
221 RETINAL VEIN OCCLUSION 6 0.0021
222 BLOOD PRESSURE FLUCTUATION 50 0.0021
223 ATRIOVENTRICULAR BLOCK 16 0.0021
224 FINGER DEFORMITY 10 0.0021
225 ENTERITIS 13 0.0020
226 PENIS DISORDER 5 0.0020
227 DERMATITIS EXFOLIATIVE GENERALISED 7 0.0020
228 INFREQUENT BOWEL MOVEMENTS 5 0.0020
229 PERSECUTORY DELUSION 5 0.0020
230 ON AND OFF PHENOMENON 11 0.0020
231 BLOOD PRESSURE SYSTOLIC DECREASED 9 0.0020
232 LUMBAR VERTEBRAL FRACTURE 9 0.0020
233 DIABETIC FOOT 6 0.0020
234 MEAN CELL VOLUME INCREASED 5 0.0019
235 PHYSICAL DECONDITIONING 5 0.0019
236 ACTINIC KERATOSIS 5 0.0019
237 BLOOD BLISTER 6 0.0019
238 FOOD INTOLERANCE 7 0.0019
239 NYSTAGMUS 10 0.0019
240 ANAEMIA MACROCYTIC 4 0.0019
241 LEFT VENTRICULAR HYPERTROPHY 8 0.0019
242 PROCTALGIA 12 0.0019
243 PRODUCT DISPENSING ERROR 40 0.0018
244 IMMOBILE 8 0.0018
245 ATRIAL FIBRILLATION 177 0.0018
246 RESPIRATORY RATE INCREASED 16 0.0018
247 INCONTINENCE 19 0.0018
248 PULMONARY HAEMORRHAGE 14 0.0018
249 ANAL INCONTINENCE 16 0.0018
250 MYALGIA 300 0.0018
251 OXYGEN SATURATION ABNORMAL 5 0.0018
252 URINE ABNORMALITY 8 0.0018
253 DUODENAL ULCER HAEMORRHAGE 5 0.0017
254 PNEUMONIA BACTERIAL 16 0.0017
255 HYPERTHERMIA 13 0.0017
256 ELECTROCARDIOGRAM QT PROLONGED 61 0.0017
257 PRODUCT RESIDUE PRESENT 9 0.0017
258 METABOLIC ENCEPHALOPATHY 5 0.0017
259 CARDIAC FAILURE ACUTE 11 0.0016
260 BUNDLE BRANCH BLOCK LEFT 7 0.0016
261 ASPIRATION 18 0.0016
262 PRODUCT PRESCRIBING ERROR 39 0.0016
263 TEARFULNESS 7 0.0016
264 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
265 DECREASED APPETITE 376 0.0016
266 BLADDER PAIN 5 0.0016
267 BILE DUCT STONE 5 0.0016
268 HEPATIC CYTOLYSIS 20 0.0016
269 BOWEL MOVEMENT IRREGULARITY 12 0.0016
270 SECOND PRIMARY MALIGNANCY 13 0.0016
271 VISION BLURRED 214 0.0016
272 PAPILLOEDEMA 7 0.0015
273 VENTRICULAR EXTRASYSTOLES 16 0.0015
274 BRADYKINESIA 9 0.0015
275 PRODUCT PREPARATION ISSUE 10 0.0015
276 FAECES SOFT 11 0.0015
277 NEPHROGENIC ANAEMIA 7 0.0015
278 ANURIA 13 0.0015
279 CLOSTRIDIUM DIFFICILE COLITIS 16 0.0015
280 CEREBRAL HAEMATOMA 5 0.0015
281 MYASTHENIA GRAVIS 12 0.0015
282 COUGH 416 0.0015
283 DELUSION 23 0.0015
284 SUPRAVENTRICULAR EXTRASYSTOLES 5 0.0015
285 CONDITION AGGRAVATED 450 0.0015
286 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 6 0.0015
287 SELF-MEDICATION 6 0.0015
288 ECCHYMOSIS 10 0.0015
289 DYSPNOEA 824 0.0015
290 FALL 484 0.0015
291 HAIR GROWTH ABNORMAL 10 0.0014
292 AORTIC STENOSIS 5 0.0014
293 SKIN EXFOLIATION 121 0.0014
294 LOWER RESPIRATORY TRACT INFECTION 65 0.0014
295 MUSCLE RIGIDITY 17 0.0014
296 ABDOMINAL PAIN 330 0.0014
297 NECROTISING FASCIITIS 5 0.0014
298 DELIRIUM 49 0.0014
299 BREAST PAIN 15 0.0014
300 INTERVERTEBRAL DISC DISORDER 6 0.0014
301 RETINAL HAEMORRHAGE 10 0.0014
302 INSOMNIA 371 0.0014
303 CORONARY ARTERY STENOSIS 7 0.0014
304 GYNAECOMASTIA 43 0.0014
305 BLOOD URIC ACID INCREASED 8 0.0014
306 KLEBSIELLA INFECTION 7 0.0014
307 ELECTROLYTE IMBALANCE 16 0.0014
308 ACUTE KIDNEY INJURY 210 0.0014
309 ASTHENIA 515 0.0014
310 MOUTH HAEMORRHAGE 10 0.0014
311 PALLOR 37 0.0014
312 BLOOD CREATINE INCREASED 6 0.0014
313 BLOOD IRON DECREASED 16 0.0013
314 RHINORRHOEA 87 0.0013
315 MALABSORPTION 7 0.0013
316 CARDIAC FAILURE 107 0.0013
317 SUSPECTED OFF LABEL USE 6 0.0013
318 POLYARTHRITIS 7 0.0013
319 HYPOKALAEMIA 61 0.0013
320 NOCTURIA 16 0.0013
321 FACE INJURY 5 0.0013
322 BLOOD URINE PRESENT 25 0.0013
323 HEPATIC FUNCTION ABNORMAL 49 0.0013
324 LIVER FUNCTION TEST ABNORMAL 38 0.0013
325 SOMNOLENCE 263 0.0013
326 SLEEP DISORDER 92 0.0013
327 HYPERTRANSAMINASAEMIA 9 0.0013
328 PNEUMONIA ASPIRATION 32 0.0013
329 PULMONARY TOXICITY 9 0.0013
330 BRADYCARDIA 67 0.0013
331 MYOCLONUS 15 0.0013
332 HYPOVOLAEMIC SHOCK 6 0.0013
333 CHOLESTASIS 24 0.0012
334 BLEPHARITIS 5 0.0012
335 OXYGEN SATURATION DECREASED 70 0.0012
336 DIZZINESS POSTURAL 12 0.0012
337 ABDOMINAL PAIN UPPER 253 0.0012
338 HAEMORRHOIDAL HAEMORRHAGE 6 0.0012
339 HYPERKALAEMIA 43 0.0012
340 POLYP 8 0.0012
341 ASPERGILLUS INFECTION 8 0.0012
342 BLOOD CREATINE PHOSPHOKINASE INCREASED 35 0.0012
343 UPPER-AIRWAY COUGH SYNDROME 10 0.0012
344 ORGANISING PNEUMONIA 6 0.0012
345 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
346 HALLUCINATION 90 0.0012
347 HALLUCINATIONS, MIXED 5 0.0012
348 TASTE DISORDER 24 0.0012
349 NEUROLEPTIC MALIGNANT SYNDROME 14 0.0012
350 PNEUMONITIS 32 0.0012
351 GAMMA-GLUTAMYLTRANSFERASE INCREASED 26 0.0012
352 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 61 0.0012
353 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 12 0.0012
354 THERAPY NON-RESPONDER 52 0.0012
355 STAPHYLOCOCCAL BACTERAEMIA 5 0.0011
356 EXTRASYSTOLES 8 0.0011
357 PULMONARY FUNCTION TEST DECREASED 5 0.0011
358 GROIN PAIN 10 0.0011
359 CARDIOMEGALY 14 0.0011
360 DUODENAL ULCER 8 0.0011
361 HYPERCALCAEMIA 14 0.0011
362 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
363 CARDIOTOXICITY 10 0.0011
364 CARDIOGENIC SHOCK 16 0.0011
365 FREQUENT BOWEL MOVEMENTS 30 0.0011
366 PANIC REACTION 8 0.0011
367 PHOTOPSIA 7 0.0011
368 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
369 HAEMOGLOBIN INCREASED 5 0.0011
370 MAJOR DEPRESSION 8 0.0011
371 CHEST DISCOMFORT 112 0.0011
372 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
373 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
374 EXPIRED PRODUCT ADMINISTERED 36 0.0011
375 GASTRIC ULCER HAEMORRHAGE 6 0.0011
376 ORAL DISCOMFORT 15 0.0011
377 ANGINA UNSTABLE 7 0.0011
378 INTRACRANIAL PRESSURE INCREASED 6 0.0011
379 BLOOD LACTATE DEHYDROGENASE INCREASED 17 0.0011
380 RECTAL HAEMORRHAGE 46 0.0011
381 ARRHYTHMIA 50 0.0011
382 CARDIAC TAMPONADE 5 0.0011
383 HYPOGLYCAEMIA 51 0.0011
384 AORTIC ANEURYSM 8 0.0011
385 MELAENA 23 0.0010
386 RESTLESS LEGS SYNDROME 19 0.0010
387 BLOOD TESTOSTERONE DECREASED 7 0.0010
388 DYSPHAGIA 97 0.0010
389 SKIN CANCER 22 0.0010
390 CARDIOMYOPATHY 15 0.0010
391 BREATH SOUNDS ABNORMAL 5 0.0010
392 MALAISE 442 0.0010
393 DIZZINESS 502 0.0010
394 FEBRILE NEUTROPENIA 66 0.0010
395 OROPHARYNGEAL PAIN 92 0.0010
396 SQUAMOUS CELL CARCINOMA OF SKIN 6 0.0010
397 INTERSTITIAL LUNG DISEASE 48 0.0010
398 DRUG-INDUCED LIVER INJURY 31 0.0010
399 PRODUCT COMPLAINT 25 0.0010
400 INGUINAL HERNIA 6 0.0010
401 GAIT DISTURBANCE 188 0.0010
402 PETIT MAL EPILEPSY 5 0.0010
403 GLOMERULAR FILTRATION RATE DECREASED 12 0.0010
404 CHOLELITHIASIS 32 0.0010
405 EAR DISCOMFORT 10 0.0010
406 MITRAL VALVE INCOMPETENCE 11 0.0010
407 WOUND 27 0.0010
408 ACUTE CORONARY SYNDROME 8 0.0010
409 PYREXIA 334 0.0010
410 ARTHRALGIA 399 0.0010
411 PAIN IN EXTREMITY 280 0.0009
412 CEREBRAL HAEMORRHAGE 34 0.0009
413 AORTIC VALVE INCOMPETENCE 4 0.0009
414 ANAL FISTULA 5 0.0009
415 ACUTE RESPIRATORY FAILURE 18 0.0009
416 ANAL FISSURE 5 0.0009
417 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 51 0.0009
418 ANAL ABSCESS 5 0.0009
419 ATAXIA 11 0.0009
420 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
421 ASPARTATE AMINOTRANSFERASE INCREASED 49 0.0009
422 HYDROCEPHALUS 5 0.0009
423 PRODUCT USE ISSUE 172 0.0009
424 PRURITUS 351 0.0009
425 FAECALOMA 5 0.0009
426 INTERNATIONAL NORMALISED RATIO INCREASED 26 0.0009
427 MUSCLE TWITCHING 21 0.0009
428 PULMONARY CONGESTION 12 0.0009
429 SARS-COV-2 TEST POSITIVE 12 0.0009
430 TOOTH FRACTURE 10 0.0009
431 TUBULOINTERSTITIAL NEPHRITIS 17 0.0009
432 HYPERKERATOSIS 5 0.0009
433 ACUTE RESPIRATORY DISTRESS SYNDROME 16 0.0009
434 BLOOD SODIUM DECREASED 17 0.0009
435 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
436 GASTRIC ULCER 17 0.0009
437 BREAST MASS 6 0.0009
438 BRAIN FOG 14 0.0009
439 SNEEZING 20 0.0009
440 GOUT 16 0.0009
441 POLLAKIURIA 37 0.0009
442 EYELID PTOSIS 9 0.0009
443 TACHYPNOEA 12 0.0009
444 BLOOD ALBUMIN DECREASED 7 0.0009
445 TRICUSPID VALVE INCOMPETENCE 7 0.0009
446 ULCER 14 0.0009
447 CYSTITIS 28 0.0009
448 BALANCE DISORDER 76 0.0009
449 DERMATITIS CONTACT 10 0.0009
450 CONSTIPATION 191 0.0009
451 MICTURITION URGENCY 10 0.0009
452 DIARRHOEA 565 0.0009
453 BLOOD GLUCOSE ABNORMAL 16 0.0009
454 MUSCLE DISORDER 7 0.0009
455 RHABDOMYOLYSIS 36 0.0009
456 ARTHRITIS INFECTIVE 4 0.0009
457 DEMENTIA 24 0.0009
458 RENAL IMPAIRMENT 72 0.0009
459 PERIPHERAL SENSORY NEUROPATHY 5 0.0009
460 PAPULE 6 0.0009
461 SQUAMOUS CELL CARCINOMA 8 0.0008
462 VENTRICULAR TACHYCARDIA 14 0.0008
463 THERMAL BURN 6 0.0008
464 URINARY INCONTINENCE 25 0.0008
465 HEART RATE IRREGULAR 19 0.0008
466 ANXIETY 239 0.0008
467 CARDIAC PACEMAKER INSERTION 5 0.0008
468 VERTIGO 51 0.0008
469 PROTHROMBIN TIME PROLONGED 5 0.0008
470 HYPONATRAEMIA 47 0.0008
471 BASAL CELL CARCINOMA 13 0.0008
472 FATIGUE 642 0.0008
473 PROSTATE CANCER 66 0.0008
474 HOSPITALISATION 126 0.0008
475 PNEUMOTHORAX 13 0.0008
476 CARDIAC OPERATION 7 0.0008
477 ALANINE AMINOTRANSFERASE INCREASED 50 0.0008
478 SMALL INTESTINAL OBSTRUCTION 10 0.0008
479 CONFUSIONAL STATE 131 0.0008
480 PIGMENTATION DISORDER 5 0.0008
481 COLON CANCER 12 0.0008
482 BACK DISORDER 13 0.0008
483 BLOOD CREATININE INCREASED 52 0.0008
484 COGNITIVE DISORDER 37 0.0008
485 HAEMODYNAMIC INSTABILITY 6 0.0008
486 DRUG LEVEL DECREASED 8 0.0008
487 FOREIGN BODY SENSATION IN EYES 5 0.0008
488 DISSEMINATED INTRAVASCULAR COAGULATION 11 0.0008
489 ANAEMIA 149 0.0008
490 MYOSITIS 7 0.0008
491 ROTATOR CUFF SYNDROME 10 0.0008
492 LACTIC ACIDOSIS 25 0.0008
493 RETINAL DETACHMENT 7 0.0008
494 BEDRIDDEN 10 0.0008
495 THERAPY CESSATION 39 0.0008
496 HALLUCINATION, VISUAL 16 0.0008
497 DISORIENTATION 30 0.0008
498 CORONAVIRUS INFECTION 5 0.0008
499 RENAL CYST 6 0.0008
500 APPETITE DISORDER 5 0.0008
501 GINGIVAL PAIN 6 0.0008
502 AGRANULOCYTOSIS 14 0.0008
503 ANORECTAL DISCOMFORT 4 0.0008
504 MIDDLE INSOMNIA 14 0.0007
505 NEPHROLITHIASIS 34 0.0007
506 CEREBRAL INFARCTION 18 0.0007
507 HAEMORRHAGE INTRACRANIAL 11 0.0007
508 SLEEP APNOEA SYNDROME 14 0.0007
509 URINARY TRACT INFECTION 125 0.0007
510 HYPERSOMNIA 21 0.0007
511 OEDEMA PERIPHERAL 89 0.0007
512 INFLUENZA 81 0.0007
513 CYST 9 0.0007
514 NIGHTMARE 25 0.0007
515 HOT FLUSH 54 0.0007
516 DEFAECATION URGENCY 5 0.0007
517 SKIN PLAQUE 6 0.0007
518 PSYCHOTIC DISORDER 21 0.0007
519 DEVICE OCCLUSION 10 0.0007
520 MUSCLE ATROPHY 9 0.0007
521 RETCHING 15 0.0007
522 HYPOTENSION 141 0.0007
523 PNEUMONIA 227 0.0007
524 PSEUDOMONAS INFECTION 6 0.0007
525 INTENTIONAL PRODUCT USE ISSUE 61 0.0007
526 APHASIA 21 0.0007
527 MUSCULAR WEAKNESS 79 0.0007
528 FULL BLOOD COUNT DECREASED 14 0.0007
529 RESPIRATORY TRACT INFECTION 18 0.0007
530 ABSCESS 11 0.0007
531 DRY THROAT 7 0.0007
532 EYELID OEDEMA 8 0.0007
533 SUBARACHNOID HAEMORRHAGE 7 0.0007
534 HYPOCALCAEMIA 13 0.0007
535 DYSSTASIA 20 0.0007
536 SEXUAL DYSFUNCTION 8 0.0007
537 IMMUNOSUPPRESSION 6 0.0007
538 LUNG INFILTRATION 6 0.0007
539 LIMB DISCOMFORT 21 0.0007
540 BLOOD PRESSURE DECREASED 45 0.0007
541 POOR VENOUS ACCESS 7 0.0007
542 DEHYDRATION 90 0.0007
543 TRANSAMINASES INCREASED 15 0.0007
544 TOOTH DISORDER 15 0.0007
545 CATARACT 40 0.0007
546 PULMONARY MASS 10 0.0007
547 RESPIRATORY DISORDER 20 0.0007
548 BLOOD BILIRUBIN INCREASED 18 0.0007
549 HYPOPHAGIA 17 0.0007
550 PRODUCT TASTE ABNORMAL 9 0.0007
551 VOMITING 312 0.0007
552 LOCALISED INFECTION 16 0.0007
553 CORONARY ARTERY DISEASE 20 0.0007
554 C-REACTIVE PROTEIN INCREASED 24 0.0007
555 EXOSTOSIS 6 0.0007
556 BLOOD UREA INCREASED 11 0.0007
557 LOSS OF CONSCIOUSNESS 84 0.0007
558 SHOCK 15 0.0007
559 POOR QUALITY SLEEP 14 0.0006
560 DECREASED ACTIVITY 7 0.0006
561 CYTOKINE RELEASE SYNDROME 13 0.0006
562 JOINT STIFFNESS 17 0.0006
563 LYMPHOMA 10 0.0006
564 MUSCULOSKELETAL CHEST PAIN 10 0.0006
565 FAECES DISCOLOURED 14 0.0006
566 ACUTE MYOCARDIAL INFARCTION 19 0.0006
567 LUNG INFECTION 10 0.0006
568 DEPRESSED MOOD 34 0.0006
569 HYPOALBUMINAEMIA 5 0.0006
570 HAEMOGLOBIN DECREASED 66 0.0006
571 FEEDING DISORDER 13 0.0006
572 HAEMORRHAGE 67 0.0006
573 SECRETION DISCHARGE 8 0.0006
574 CELLULITIS 32 0.0006
575 FLATULENCE 36 0.0006
576 FRACTURE 12 0.0006
577 RIB FRACTURE 13 0.0006
578 CHRONIC KIDNEY DISEASE 48 0.0006
579 FOOT DEFORMITY 7 0.0006
580 MYELODYSPLASTIC SYNDROME 9 0.0006
581 SENSORY LOSS 5 0.0006
582 SKIN LESION 17 0.0006
583 AGGRESSION 31 0.0006
584 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 111 0.0006
585 PRODUCT AVAILABILITY ISSUE 14 0.0006
586 SHOCK HAEMORRHAGIC 5 0.0006
587 DIVERTICULITIS 17 0.0006
588 METASTASES TO BONE 10 0.0006
589 PLEURAL EFFUSION 37 0.0006
590 HOSPICE CARE 6 0.0006
591 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
592 LIGAMENT SPRAIN 6 0.0006
593 COLITIS 23 0.0006
594 WEIGHT DECREASED 169 0.0006
595 THERAPEUTIC RESPONSE SHORTENED 20 0.0006
596 PULMONARY OEDEMA 27 0.0006
597 OFF LABEL USE 527 0.0006
598 THROMBOCYTOPENIA 67 0.0006
599 JAUNDICE 16 0.0006
600 INTENTIONAL PRODUCT MISUSE 52 0.0006
601 PRODUCT USE IN UNAPPROVED INDICATION 147 0.0006
602 PERIPHERAL SWELLING 91 0.0006
603 THINKING ABNORMAL 11 0.0006
604 LIMB INJURY 16 0.0006
605 THERAPY INTERRUPTED 42 0.0006
606 HIP ARTHROPLASTY 9 0.0006
607 FACIAL PARALYSIS 5 0.0006
608 HEADACHE 366 0.0006
609 CHEST PAIN 108 0.0006
610 PLATELET COUNT DECREASED 62 0.0006
611 COLITIS ULCERATIVE 26 0.0006
612 CHROMATURIA 13 0.0006
613 PRODUCT SUBSTITUTION ISSUE 33 0.0006
614 RENAL FAILURE 76 0.0006
615 OEDEMA 31 0.0006
616 PRODUCT USE COMPLAINT 9 0.0006
617 GAIT INABILITY 19 0.0006
618 DRY MOUTH 46 0.0006
619 PRODUCT COMMUNICATION ISSUE 5 0.0006
620 PRODUCT DOSE OMISSION IN ERROR 16 0.0006
621 DYSPHONIA 33 0.0006
622 HAEMORRHOIDS 11 0.0006
623 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
624 PERICARDIAL EFFUSION 13 0.0006
625 HYPERTENSION 119 0.0006
626 HAEMATOCHEZIA 31 0.0006
627 BODY HEIGHT DECREASED 6 0.0006
628 ISCHAEMIC STROKE 10 0.0006
629 RED BLOOD CELL COUNT DECREASED 16 0.0006
630 PARALYSIS 8 0.0006
631 ANGINA PECTORIS 16 0.0006
632 HYPOACUSIS 24 0.0006
633 MOBILITY DECREASED 40 0.0006
634 HAEMATOCRIT DECREASED 11 0.0006
635 PANCYTOPENIA 31 0.0006
636 BLOOD POTASSIUM INCREASED 9 0.0006
637 ABDOMINAL PAIN LOWER 14 0.0006
638 LEUKOCYTOSIS 10 0.0006
639 CLOSTRIDIUM DIFFICILE INFECTION 12 0.0005
640 PRODUCT STORAGE ERROR 48 0.0005
641 INTRAOCULAR PRESSURE INCREASED 7 0.0005
642 GASTROINTESTINAL PAIN 6 0.0005
643 ERYTHEMA MULTIFORME 5 0.0005
644 NEPHROPATHY 5 0.0005
645 FLANK PAIN 5 0.0005
646 TOOTH INFECTION 7 0.0005
647 CONTUSION 51 0.0005
648 MYOCARDIAL ISCHAEMIA 6 0.0005
649 ABDOMINAL DISTENSION 55 0.0005
650 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 9 0.0005
651 HERPES ZOSTER 30 0.0005
652 NAUSEA 413 0.0005
653 QUALITY OF LIFE DECREASED 7 0.0005
654 BACK PAIN 121 0.0005
655 AFFECT LABILITY 5 0.0005
656 SINUS CONGESTION 7 0.0005
657 SINUS BRADYCARDIA 5 0.0005
658 ANKLE FRACTURE 8 0.0005
659 EOSINOPHILIA 9 0.0005
660 LABORATORY TEST ABNORMAL 15 0.0005
661 KNEE OPERATION 5 0.0005
662 COVID-19 PNEUMONIA 6 0.0005
663 AMNESIA 33 0.0005
664 HEAD INJURY 16 0.0005
665 GALLBLADDER DISORDER 9 0.0005
666 BLADDER DISORDER 5 0.0005
667 TOXIC SKIN ERUPTION 5 0.0005
668 ARTHRITIS 39 0.0005
669 OSTEOARTHRITIS 21 0.0005
670 NEUTROPHIL COUNT DECREASED 20 0.0005
671 AGITATION 36 0.0005
672 HYPERHIDROSIS 63 0.0005
673 NEUTROPHIL COUNT INCREASED 5 0.0005
674 ABNORMAL FAECES 4 0.0005
675 DYSPEPSIA 48 0.0005
676 PLASMA CELL MYELOMA 19 0.0005
677 PHOTOSENSITIVITY REACTION 8 0.0005
678 GENERAL PHYSICAL HEALTH DETERIORATION 56 0.0005
679 DRUG LEVEL INCREASED 8 0.0005
680 ILEUS 6 0.0005
681 INFUSION RELATED REACTION 32 0.0005
682 HYPERBILIRUBINAEMIA 5 0.0005
683 HYPOKINESIA 7 0.0005
684 HAIR COLOUR CHANGES 6 0.0005
685 TOOTH EXTRACTION 6 0.0005
686 EPISTAXIS 36 0.0005
687 EYE DISCHARGE 5 0.0005
688 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
689 APATHY 7 0.0005
690 DEPRESSION 109 0.0005
691 COVID-19 84 0.0005
692 PRODUCT ODOUR ABNORMAL 5 0.0005
693 TRANSFUSION 5 0.0005
694 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
695 SCRATCH 5 0.0005
696 PROTEINURIA 9 0.0005
697 NEUROPATHY PERIPHERAL 45 0.0005
698 CIRCULATORY COLLAPSE 8 0.0005
699 EATING DISORDER 10 0.0005
700 JOINT INJURY 10 0.0005
701 GLAUCOMA 9 0.0005
702 NASOPHARYNGITIS 86 0.0005
703 NIGHT SWEATS 15 0.0005
704 ERUCTATION 9 0.0005
705 PRESCRIBED OVERDOSE 9 0.0005
706 PARANOIA 8 0.0005
707 HIATUS HERNIA 6 0.0005
708 PLATELET COUNT INCREASED 6 0.0005
709 LEUKOPENIA 23 0.0005
710 ECZEMA 24 0.0005
711 STAPHYLOCOCCAL INFECTION 15 0.0005
712 BLOOD PRESSURE ABNORMAL 9 0.0005
713 LYMPHOCYTE COUNT DECREASED 8 0.0005
714 PALPITATIONS 53 0.0005
715 FLUID RETENTION 23 0.0005
716 DENTAL CARIES 5 0.0005
717 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
718 LIVER DISORDER 20 0.0005
719 ARTHROPATHY 25 0.0004
720 RASH MACULO-PAPULAR 10 0.0004
721 THIRST 8 0.0004
722 MALNUTRITION 5 0.0004
723 PRODUCT PHYSICAL ISSUE 9 0.0004
724 BONE PAIN 26 0.0004
725 RASH PRURITIC 24 0.0004
726 MUSCLE SPASMS 81 0.0004
727 RESPIRATORY TRACT CONGESTION 7 0.0004
728 FEELING HOT 27 0.0004
729 DISEASE PROGRESSION 52 0.0004
730 SCAB 5 0.0004
731 LUNG NEOPLASM MALIGNANT 18 0.0004
732 INTERNAL HAEMORRHAGE 5 0.0004
733 CORONARY ARTERY OCCLUSION 6 0.0004
734 MYOCARDITIS 5 0.0004
735 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
736 CARDIAC FAILURE CONGESTIVE 35 0.0004
737 GASTROINTESTINAL DISORDER 39 0.0004
738 HIP FRACTURE 14 0.0004
739 MUSCULOSKELETAL STIFFNESS 38 0.0004
740 METASTASES TO LUNG 5 0.0004
741 BLOOD POTASSIUM DECREASED 13 0.0004
742 ERYTHEMA 88 0.0004
743 SKIN REACTION 6 0.0004
744 SKIN ULCER 11 0.0004
745 SEIZURE 49 0.0004
746 ABDOMINAL DISCOMFORT 71 0.0004
747 BACTERAEMIA 5 0.0004
748 CYTOMEGALOVIRUS INFECTION 7 0.0004
749 DEAFNESS 11 0.0004
750 LIP SWELLING 14 0.0004
751 SPEECH DISORDER 22 0.0004
752 LIVER FUNCTION TEST INCREASED 9 0.0004
753 DRUG PRESCRIBING ERROR 8 0.0004
754 TREMOR 69 0.0004
755 ATELECTASIS 4 0.0004
756 HERNIA 8 0.0004
757 RASH 180 0.0004
758 ADVERSE DRUG REACTION 37 0.0004
759 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
760 NECK PAIN 23 0.0004
761 NEURALGIA 10 0.0004
762 GASTROENTERITIS 6 0.0004
763 NASAL CONGESTION 24 0.0004
764 RENAL DISORDER 19 0.0004
765 SINUS DISORDER 8 0.0004
766 IMMUNODEFICIENCY 6 0.0004
767 RASH PAPULAR 9 0.0004
768 THROAT IRRITATION 18 0.0004
769 LETHARGY 23 0.0004
770 DYSARTHRIA 15 0.0004
771 METASTASES TO LIVER 7 0.0004
772 INTESTINAL OBSTRUCTION 15 0.0004
773 RESPIRATORY FAILURE 29 0.0004
774 TOXIC EPIDERMAL NECROLYSIS 6 0.0004
775 DYSKINESIA 16 0.0004
776 DISTURBANCE IN ATTENTION 21 0.0004
777 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
778 UNRESPONSIVE TO STIMULI 10 0.0004
779 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
780 HAEMATOMA 10 0.0004
781 ACUTE MYELOID LEUKAEMIA 6 0.0004
782 DEATH 328 0.0004
783 IMMUNE SYSTEM DISORDER 5 0.0004
784 MEDICATION ERROR 21 0.0004
785 ADVERSE REACTION 5 0.0004
786 SCIATICA 6 0.0004
787 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
788 NEOPLASM MALIGNANT 25 0.0004
789 BLISTER 21 0.0004
790 HAIR TEXTURE ABNORMAL 5 0.0004
791 MOVEMENT DISORDER 12 0.0004
792 MALIGNANT MELANOMA 5 0.0004
793 SUICIDAL IDEATION 34 0.0004
794 CEREBROVASCULAR ACCIDENT 62 0.0004
795 BRONCHITIS 27 0.0004
796 LOWER LIMB FRACTURE 7 0.0004
797 PERIPHERAL COLDNESS 5 0.0004
798 EPILEPSY 11 0.0004
799 SKIN DISORDER 12 0.0004
800 PANCREATITIS 19 0.0004
801 FEELING COLD 10 0.0004
802 GASTROINTESTINAL HAEMORRHAGE 30 0.0004
803 MASS 5 0.0004
804 KIDNEY INFECTION 7 0.0004
805 TYPE 2 DIABETES MELLITUS 12 0.0004
806 ACCIDENTAL OVERDOSE 13 0.0004
807 BLOOD GLUCOSE DECREASED 17 0.0004
808 HEART RATE INCREASED 35 0.0004
809 CARDIAC ARREST 29 0.0004
810 INTENTIONAL DOSE OMISSION 10 0.0004
811 ANAPHYLACTIC SHOCK 9 0.0003
812 SKIN DISCOLOURATION 16 0.0003
813 VISUAL IMPAIRMENT 43 0.0003
814 PARAESTHESIA ORAL 5 0.0003
815 MYOCARDIAL INFARCTION 60 0.0003
816 MUCOSAL INFLAMMATION 9 0.0003
817 NEUROTOXICITY 6 0.0003
818 BURNING SENSATION 24 0.0003
819 MALIGNANT NEOPLASM PROGRESSION 35 0.0003
820 DRY EYE 17 0.0003
821 BLADDER CANCER 20 0.0003
822 WEIGHT INCREASED 76 0.0003
823 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
824 DISEASE RECURRENCE 16 0.0003
825 PULMONARY HYPERTENSION 7 0.0003
826 RASH ERYTHEMATOUS 16 0.0003
827 KNEE ARTHROPLASTY 7 0.0003
828 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
829 OSTEOMYELITIS 6 0.0003
830 LACRIMATION INCREASED 10 0.0003
831 MOOD ALTERED 9 0.0003
832 ILL-DEFINED DISORDER 20 0.0003
833 END STAGE RENAL DISEASE 6 0.0003
834 UNDERDOSE 24 0.0003
835 THYROID DISORDER 5 0.0003
836 TENDONITIS 5 0.0003
837 MENTAL DISORDER 14 0.0003
838 AGEUSIA 8 0.0003
839 TARDIVE DYSKINESIA 9 0.0003
840 RASH MACULAR 11 0.0003
841 METABOLIC ACIDOSIS 10 0.0003
842 ORAL PAIN 7 0.0003
843 PANCREATITIS ACUTE 7 0.0003
844 LYMPHADENOPATHY 11 0.0003
845 ROAD TRAFFIC ACCIDENT 13 0.0003
846 INFLAMMATION 16 0.0003
847 DYSGEUSIA 23 0.0003
848 RASH GENERALISED 8 0.0003
849 EXPOSURE VIA SKIN CONTACT 8 0.0003
850 SURGERY 18 0.0003
851 PRODUCT DOSE OMISSION ISSUE 90 0.0003
852 EYE DISORDER 10 0.0003
853 GASTRITIS 8 0.0003
854 ADVERSE EVENT 28 0.0003
855 HYPERGLYCAEMIA 11 0.0003
856 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 61 0.0003
857 DRUG ABUSE 25 0.0003
858 JOINT SWELLING 36 0.0003
859 INJECTION SITE MASS 11 0.0003
860 PAIN OF SKIN 8 0.0003
861 INTENTIONAL SELF-INJURY 6 0.0003
862 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
863 HEMIPARESIS 5 0.0003
864 DISCOMFORT 18 0.0003
865 BODY TEMPERATURE INCREASED 6 0.0003
866 SINUSITIS 30 0.0003
867 TREATMENT NONCOMPLIANCE 16 0.0003
868 PRODUCT PREPARATION ERROR 6 0.0003
869 OSTEOPOROSIS 12 0.0003
870 PRODUCT DOSE OMISSION 19 0.0003
871 HYPERSENSITIVITY 54 0.0003
872 MUSCULOSKELETAL DISCOMFORT 5 0.0003
873 RESPIRATORY DISTRESS 8 0.0003
874 DRUG INTOLERANCE 28 0.0003
875 ABNORMAL DREAMS 8 0.0003
876 CARDIAC DISORDER 27 0.0003
877 NERVOUSNESS 15 0.0003
878 APHONIA 4 0.0003
879 MUSCULOSKELETAL PAIN 15 0.0003
880 DRY SKIN 38 0.0003
881 COLD SWEAT 5 0.0003
882 MOOD SWINGS 9 0.0003
883 INTENTIONAL OVERDOSE 18 0.0003
884 STOMATITIS 17 0.0003
885 FEELING ABNORMAL 67 0.0003
886 HEPATIC ENZYME INCREASED 19 0.0003
887 DEEP VEIN THROMBOSIS 18 0.0003
888 GASTROENTERITIS VIRAL 5 0.0003
889 PANIC ATTACK 10 0.0003
890 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
891 EXTRA DOSE ADMINISTERED 11 0.0003
892 ANGIOEDEMA 12 0.0003
893 VISUAL ACUITY REDUCED 9 0.0003
894 VIRAL INFECTION 9 0.0003
895 STEVENS-JOHNSON SYNDROME 6 0.0003
896 HEPATOTOXICITY 6 0.0003
897 BACTERIAL INFECTION 5 0.0003
898 DEVICE ISSUE 24 0.0003
899 SWELLING 25 0.0003
900 HEPATIC CIRRHOSIS 5 0.0003
901 PAIN 163 0.0003
902 INFECTION 38 0.0003
903 EYE IRRITATION 15 0.0003
904 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
905 RENAL FAILURE ACUTE 11 0.0003
906 THROAT TIGHTNESS 7 0.0003
907 FEMUR FRACTURE 8 0.0003
908 SWOLLEN TONGUE 8 0.0003
909 SKIN FISSURES 5 0.0003
910 INFLUENZA LIKE ILLNESS 21 0.0003
911 PARAESTHESIA 40 0.0003
912 SEPTIC SHOCK 11 0.0003
913 ABNORMAL BEHAVIOUR 10 0.0003
914 MENTAL STATUS CHANGES 7 0.0003
915 UPPER LIMB FRACTURE 5 0.0003
916 URTICARIA 42 0.0003
917 PRESCRIBED UNDERDOSE 5 0.0003
918 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
919 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
920 DRUG INEFFECTIVE 320 0.0002
921 OSTEONECROSIS OF JAW 6 0.0002
922 TOOTH LOSS 5 0.0002
923 INCORRECT DOSE ADMINISTERED 55 0.0002
924 DERMATITIS 5 0.0002
925 EYE PRURITUS 8 0.0002
926 ANGER 8 0.0002
927 OVERDOSE 51 0.0002
928 ALOPECIA 46 0.0002
929 OCULAR HYPERAEMIA 11 0.0002
930 NEOPLASM PROGRESSION 8 0.0002
931 GLOSSODYNIA 5 0.0002
932 ILLNESS 23 0.0002
933 BLOOD GLUCOSE INCREASED 42 0.0002
934 PSORIATIC ARTHROPATHY 9 0.0002
935 HYPOAESTHESIA 33 0.0002
936 DRUG EFFECT INCOMPLETE 8 0.0002
937 RESTLESSNESS 8 0.0002
938 SWELLING FACE 14 0.0002
939 BLOOD CHOLESTEROL INCREASED 10 0.0002
940 PAIN IN JAW 6 0.0002
941 MEMORY IMPAIRMENT 29 0.0002
942 INJECTION SITE ERYTHEMA 26 0.0002
943 DIABETIC KETOACIDOSIS 5 0.0002
944 TOXICITY TO VARIOUS AGENTS 35 0.0002
945 NEUTROPENIA 28 0.0002
946 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
947 IRRITABILITY 12 0.0002
948 HEPATIC FAILURE 6 0.0002
949 DIABETES MELLITUS 15 0.0002
950 FLUSHING 20 0.0002
951 HEPATITIS 5 0.0002
952 CRYING 7 0.0002
953 ANHEDONIA 5 0.0002
954 DERMATITIS ATOPIC 10 0.0002
955 MULTIPLE SCLEROSIS 9 0.0002
956 EYE SWELLING 7 0.0002
957 RHEUMATOID ARTHRITIS 21 0.0002
958 ACNE 14 0.0002
959 PSORIASIS 24 0.0002
960 SUICIDE ATTEMPT 11 0.0002
961 APPLICATION SITE PRURITUS 4 0.0002
962 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
963 UNEVALUABLE EVENT 13 0.0002
964 RENAL CANCER 8 0.0002
965 INJECTION SITE PAIN 49 0.0002
966 TREATMENT FAILURE 13 0.0002
967 IMPAIRED HEALING 5 0.0002
968 OSTEONECROSIS 5 0.0002
969 INJECTION SITE HAEMORRHAGE 12 0.0002
970 EXPOSURE DURING PREGNANCY 9 0.0001
971 INJECTION SITE SWELLING 11 0.0001
972 DEVICE DISLOCATION 6 0.0001
973 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
974 INJECTION SITE BRUISING 10 0.0001
975 PRODUCT QUALITY ISSUE 17 0.0001
976 NO ADVERSE EVENT 22 0.0001
977 THERAPEUTIC RESPONSE DECREASED 7 0.0001
978 INJURY 8 0.0001
979 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
980 DEVICE DIFFICULT TO USE 7 0.0001
981 DRUG DOSE OMISSION 17 0.0001
982 DEVICE MALFUNCTION 7 0.0001
983 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
984 ANAPHYLACTIC REACTION 5 0.0001
985 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
986 INJECTION SITE PRURITUS 5 0.0001
987 BREAST CANCER 6 0.0001
988 MIGRAINE 6 0.0001
989 COMPLETED SUICIDE 5 0.0001